We are Sorry, This Page doesn't Exist
Genentech announces Remdacta study did not meet primary, key secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer: Xeljanz study in RA did not meet co-primary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novartis Phase III ruxolitinib study treating Covid did not meet endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Oyster Point Pharma announces ONSET-2 study meets primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Menlo Therapeutics says Study MTI-105, Study MTI-106 did not meet endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
William Blair maintains Outperform on Biohaven after study meets endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vanda Pharma: Phase 3 study of tradipitant did not meet primary endpoint
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck stock slides as lung-cancer drug misses a study endpoint
Merck & Co. shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0......»»
Incyte GRAVITAS-301 study does not meet primary, secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mereo BioPharma: Phase 2b ASTEROID study did not meet primary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Merck KGaA and Pfizer said Friday that a late-stage clinical trial testing Bavencio as a first-line maintenance treatment for patients with certain forms of gastric cancer failed to meet the study's primary endpoints for survival. The cur.....»»
Catalyst Pharmaceuticals: CMS-001 Phase 3 study did not meet endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Concert plunges after Avanir"s phase 3 study of AVP-786 does not meet endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Retrophin down 25% to $13.01 after Phase 3 FORT Study did not meet endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Retrophin says Phase 3 FORT Study did not meet primary or secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pfizer: Phase 3 rivipansel study did not meet primary, key secondary endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Big carmakers including VW, FCA could face 2021 EU emissions fines - study
Volkswagen and FiatChrysler could together face billions of dollars in penalties if they fail to meet the European Union's emissions targets set for 2021, according to a new study. David Pollard reports......»»
Large carmakers including Volkswagen, FCA could face 2021 EU emissions fines: study
Volkswagen and FiatChrysler could face penalties of up to 1.83 billion euros ($2.08 billion) and 746 million euros respectively, if they fail to meet the European Union's emissions targets set for 2021, according to AlixPartners......»»
Incyte, Merck announce ECHO-301/KEYNOTE-252 study did not meet endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
vTv says Part B of STEADFAST Study did not meet co-primary efficacy endpoints
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»